- Published at
- by manilatimes.net
positive
positive
News for Spruce Biosciences, Inc. (SPRB)
- Published at
- by investing.com
positivepositiveSPRB stock touches 52-week low at $0.37 amid market challenges By Investing.com
SPRB stock touches 52-week low at $0.37 amid market challenges- Published at
- by zacks.com
neutralneutralSpruce Biosciences (SPRB) Upgraded to Buy: Here's Why
Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).- Published at
- by zacks.com
negativenegativeSpruce Biosciences, Inc. (SPRB) Reports Q3 Loss, Lags Revenue Estimates
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 22.22% and 66.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by zacks.com
positivepositiveSpruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 33.33% and 3.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by investing.com
neutralneutralSPRB stock touches 52-week low at $0.42 amid market challenges By Investing.com
SPRB stock touches 52-week low at $0.42 amid market challenges- Published at
- by investing.com
neutralneutralOppenheimer cuts Spruce Biosciences shares target, cites updated revenue forecasts By Investing.com
Oppenheimer cuts Spruce Biosciences shares target, cites updated revenue forecasts- Published at
- by investing.com
neutralneutralSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD) By Investing.com
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)- Published at
- by marketscreener.com
mixedmixedSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today...- Published at
- by zacks.com
positivepositiveSpruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 12.50% and 79.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by benzinga.com
mixedmixedWhy Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session - Limbach Holdings (NASDAQ:LMB)
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.WIMIVRM.MXVRMUNCYTCONSRGLSQLIPIXYPIPATHP2AT34.SANXPIMDGLLMBLAC.TOLACHEARFUTUN.MXFUTUEBDSG.DEDKSBBWAUUDWAUUDAPM0ZNF.L0J9J.LUAAC.MXUAA.MXUAAUAU9RA.DEU9R.DEU1AI34.SAPUYIPANLNOVAMOMOKPLTGIIIFSR-WTFSREGY.LEGYBUDFFBUDANH.JOANB.MXAFRM.MXAFRMABUD34.SAABI.MIABI.BR1NBA.DE0R2I.L0LIK.LWOOF.MXWOOFSPROSPRBRMBLRCMTHOOD- Published at
- by rttnews.com
mixedmixedPre-market Movers: SPRB, CCTG, HEAR, LAC, DHCA…
California-based biopharmaceutical company Spruce Biosciences, Inc. (SPRB) is down over 77% in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.- Published at
- by benzinga.com
mixedmixedWhy Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Robinhood Markets (NASDAQ:HOOD)
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.- Published at
- by globenewswire.com
positivepositiveSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...- Published at
- by rttnews.com
mixedmixed- Published at
- by rttnews.com
mixedmixed- Published at
- by globenewswire.com
mixedmixedGRI Bio (NASDAQ: GRI) Announces Board of Director Appointments Adding Leadership and Expertise Spanning a Combined 75 Years in Both Public and Private Sectors in the Life Sciences Industry
LA JOLLA, CA, April 24, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...ZIVOPFED.BAPFECL.SNPFE.MXPFE.DEPFEMDNA.TOMDNAJAZZHARPFUSNCODXCAPRBNTXN.MXBNTX0A50.L0A3M.LZLDPFZIOPZGNXZEALXCURVYNEVYGR.MXVYGRVECTTXMDTRVNTRIL.TOTRILTLGTTFFPTARASPRBSONNRVMDRPIDRMTIPROGPRAXPMCBDPMCBPBLAPASGORTXNKTRNBIXMRNA.MXMRNAMNOVMBRXM1RN34.SALVTXLUMOLMNLKRONKPTIKNSAJAGXITRMIRWDIRTCINCYINABIMRAIKTI1NC34.SAHRTXHOTHHOOKHBIOGTBPGRFSGRFPN.MXGRF.MCGIS.DEGILDD.BAGILD.MXGILDGIKLYGIFOFGIFLFFMTXFLXNFGEN.MXFGENEYEGEWTXEPZMENSCWENSCDVAXDRNADMACCTMXCLRBCELUBXRXBUWA.DEBPTHBMEABIOLBIO-BBIOBDSXBAX.MXBAXAYTUAXSMATAIARDSALLOALKSALIMAKROAGLEACHLACAD4875.T0UNL.L0QK8.L0M3O.L0K6R.L0J9P.L0J4V.L0IL8.L0IDA.L0HKF.L0A8M.L0A7L.L0A4W.L0A45.LSESNJNJINVADJNJ3.BADJNJ2.BAARNAAPREABVC0S54.L- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was ...- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 51 stocks hit new 52-week lows. Noteables: PG&E (NYSE:PCG) was the biggest company in terms of market cap to set ...